当前位置: 首页 > 期刊 > 《医学信息》 > 2024年第14期
编号:2291263
脑胶质瘤术后复发与假性进展的MRI鉴别诊断研究进展
http://www.100md.com 2024年12月31日 医学信息 2024年第14期
     摘要:脑胶质瘤是最常见的原发性脑肿瘤,在患者术后随访期间,如果出现新的强化病灶,影像学可能考虑为肿瘤复发或假性进展(PsP)。鉴别胶质瘤治疗后复发或假性进展对于患者后续治疗方式至关重要,而MRI在区分胶质瘤治疗后复发与假性进展具有明显优势。本文主要对脑胶质瘤术后复发与假性进展的MRI研究进展进行综述,总结了不同扫描技术、不同诊断方法对脑胶质瘤术后复发与假性进展的应用现状,立足于对两者充分认识及影像诊断技术的灵活应用,以期提高诊断准确率、降低误诊率。

    关键词:脑胶质瘤;假性进展;核磁共振成像

    中图分类号:R739.41" " " " " " " " " " " " " " " "文献标识码:A" " " " " " " " " " " " " " " " "DOI:10.3969/j.issn.1006-1959.2024.14.039

    文章编号:1006-1959(2024)14-0183-05

    Research Progress in MRI Differential Diagnosis of Postoperative Recurrence

    and Pseudoprogression of Glioma

    LI Bo-wei1,2,3,DI Duo-duo1,2,3,HE Si-yi3,CHENG Guan-xun1,2,3

    (1.Clinical College of Peking University Shenzhen Hospital,Anhui Medical University,Shenzhen 518036,Guangdong,China;

    2.The Fifth Clinical Medical College of Anhui Medical University,Hefei 230000,Anhui,China;

    3.Department of Radiology,Peking University Shenzhen Hospital,Shenzhen 518036,Guangdong,China)

    Abstract:Glioma is the most common primary brain tumor. During the postoperative follow-up period, if new enhanced lesions appear, imaging may be considered as tumor recurrence or pseudoprogression (PsP). Identifying recurrence or pseudoprogression after glioma treatment is crucial for the follow-up treatment of patients ......

您现在查看是摘要页,全文长 19234 字符